Dualitybio Inc.
Clinical trials sponsored by Dualitybio Inc., explained in plain language.
-
New hope for advanced cancer: experimental drug DB-1311 enters human trials
Disease control Recruiting nowThis study tests a new drug, DB-1311/BNT324, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 862 adults will take part in this early-pha…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 29, 2026 11:29 UTC
-
New lupus shot enters human testing – could it tame the disease?
Disease control Recruiting nowThis study tests an experimental injection called DB-2304 in healthy volunteers and people with lupus (SLE or CLE). The main goal is to check safety and side effects, not to cure the disease. About 148 participants will be monitored closely. If safe, the drug may help control lup…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 29, 2026 11:28 UTC